- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/712 - Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose
Patent holdings for IPC class A61K 31/712
Total number of patents in this class: 1692
10-year publication summary
|
90
|
101
|
104
|
121
|
157
|
147
|
154
|
196
|
155
|
41
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ionis Pharmaceuticals, Inc. | 845 |
115 |
| Alnylam Pharmaceuticals, Inc. | 1140 |
44 |
| F. Hoffmann-La Roche AG | 7889 |
31 |
| Hoffmann-La Roche Inc. | 3341 |
30 |
| Nippon Shinyaku Co., Ltd. | 328 |
26 |
| Osaka University | 3323 |
26 |
| Wave Life Sciences Ltd. | 160 |
25 |
| Sarepta Therapeutics, Inc. | 365 |
23 |
| Roche Innovation Center Copenhagen A/S | 132 |
22 |
| University of Massachusetts | 2192 |
21 |
| Avidity Biosciences, Inc. | 133 |
19 |
| Isis Pharmaceuticals, Inc. | 221 |
17 |
| National Center of Neurology and Psychiatry | 146 |
15 |
| Centre National de La Recherche Scientifique | 10165 |
14 |
| Arrowhead Pharmaceuticals, Inc. | 291 |
14 |
| Replicor Inc. | 29 |
14 |
| Sirnaomics, Inc. | 111 |
14 |
| The Regents of the University of California | 19661 |
13 |
| CuRNA, Inc. | 131 |
13 |
| Aligos Therapeutics, Inc. | 147 |
13 |
| Other owners | 1183 |